Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

58.75
-1.8400-3.04%
Post-market: 58.750.00000.00%19:55 EDT
Volume:3.32M
Turnover:197.27M
Market Cap:33.90B
PE:31.51
High:60.71
Open:60.45
Low:58.64
Close:60.59
52wk High:64.38
52wk Low:34.63
Shares:576.94M
Float Shares:392.53M
Volume Ratio:0.75
T/O Rate:0.85%
Dividend:0.91
Dividend Rate:1.55%
EPS(TTM):1.86
EPS(LYR):1.78
ROE:13.97%
ROA:5.09%
PB:4.96
PE(LYR):32.98

Loading ...

Royalty Pharma to report first-quarter results, host conference call and webcast

Reuters
·
Apr 16

Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026

THOMSON REUTERS
·
Apr 16

Royalty Pharma announces annual shareholder meeting

Reuters
·
Apr 11

Royalty Pharma Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Apr 11

Royalty Pharma price target raised to $63 from $61 at Morgan Stanley

TIPRANKS
·
Apr 10

Royalty Pharma CFO Terrance Coyne reports $1.7 million Class A share sale

Reuters
·
Apr 03

Zymeworks Appoints Kristin Stafford CFO

MT Newswires Live
·
Apr 01

Zymeworks appoints Kristin Stafford as CFO effective April 1, 2026

Reuters
·
Apr 01

Royalty Pharma reports co-funding agreement with Johnson & Johnson for JNJ-4804

TIPRANKS
·
Mar 30

Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases

THOMSON REUTERS
·
Mar 30

Royalty Pharma - Announces $500 Mln R&D Co-Funding Agreement With Johnson & Johnson for 2026-2027

THOMSON REUTERS
·
Mar 30

Royalty Pharma - Agreement to Advance Development of Jnj-4804 for Autoimmune Diseases

THOMSON REUTERS
·
Mar 30

Royalty Pharma; EVP & CFO Terrance P. Coyne reports common share disposal valued at $1,583,000

Reuters
·
Mar 26

How Royalty Pharma’s New AI and Dealmaking Hires Could Shape RPRX’s Royalty Sourcing Strategy

Simply Wall St.
·
Mar 25

Press Release: Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence

Dow Jones
·
Mar 23

S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Royalty Pharma Lag

Dow Jones
·
Mar 20

Press Release: Royalty Pharma Announces Expansion of Leadership Team

Dow Jones
·
Mar 18